Growth factors and flap survival

Related Experiment Video

Updated: Aug 24, 2026

In situ Transverse Rectus Abdominis Myocutaneous Flap: A Rat Model of Myocutaneous Ischemia Reperfusion Injury
11:12

In situ Transverse Rectus Abdominis Myocutaneous Flap: A Rat Model of Myocutaneous Ischemia Reperfusion Injury

Published on: June 8, 2013

Feng Zhang1, William Waller, William C Lineaweaver

  • 1Division of Plastic Surgery, University of Mississippi Medical Center, Jackson, MS 39216, USA.

Microsurgery
|May 26, 2004
PubMed

Insights

Growth factors are key polypeptide regulators influencing cell activities. Their therapeutic use in wound healing and skin flap survival, including roles in angiogenesis and gene therapy, is reviewed.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Growth factors are polypeptide regulators impacting cell functions.
  • Therapeutic applications of growth factors for wound healing and ischemic skin flaps are gaining interest.
  • Understanding growth factor regulation is crucial for regenerative therapies.

Purpose of the Study:

  • To review the literature on growth factor regulation in flaps.
  • To explore the role of angiogenesis in flap survival and maturation.
  • To assess the impact of growth factors on flap metabolism and potential gene therapy applications.

Main Methods:

  • Literature review of scientific articles.
  • Analysis of studies on growth factor regulation.
  • Synthesis of data on angiogenesis and flap survival.
  • Evaluation of growth factor effects on flap metabolism.

Main Results:

  • Growth factors significantly influence cellular activities and tissue regeneration.
  • Angiogenesis plays a critical role in the survival and maturation of skin flaps.
  • Growth factors impact flap metabolism, supporting tissue viability.
  • Gene therapy presents a potential future application for growth factor delivery.

Conclusions:

  • Growth factors are vital for wound healing and flap viability.
  • Targeting angiogenesis with growth factors is a promising therapeutic strategy.
  • Further research into growth factor applications, including gene therapy, is warranted.

More Related Videos

Engineered Vascularized Muscle Flap08:18

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

An Experimental Human DIEP Flap Model to Investigate Preservation Strategies for Vascularized Composite Allografts and Free Flaps07:57

An Experimental Human DIEP Flap Model to Investigate Preservation Strategies for Vascularized Composite Allografts and Free Flaps

Published on: December 5, 2025

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...